Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis iap'

Search results for: 'research area apoptosis iap'

Items 51-60 of 65

Page
per page
  1. Clemizole hydrochloride
    A3316 Clemizole hydrochloride
    Target: Histamine H1 Receptors|TRPC channel
    Summary: H1 histamine receptor antagonist
  2. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      insoluble in H2O; ≥91 mg/mL
  3. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
  4. 1-Deoxynojirimycin
    N1659 1-Deoxynojirimycin
    Target: Glucosidases
    Summary: anti-cancer medicine
      insoluble in EtOH; ≥16.13 mg/mL
  5. Toyocamycin
    B7795 Toyocamycin
    Target: phosphatidylinositol kinase
    Summary: Adenosine analog,antitumor antibiotic
      ≥77 mg/mL
  6. Apigenin
    N1828 Apigenin
    Target: Cytochrome P450 (CYP450)
    Summary: Antioxidant plant flavanoid
      insoluble in EtOH; insoluble in H2O; ≥9.8 mg/mL
  7. Tanshinone IIA
    N1846 Tanshinone IIA
    Target: AP-1|MAGL
    Summary: Antioxidant and anti-inflammatory reagent
      insoluble in EtOH; insoluble in H2O; ≥3.42 mg/mL
  8. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  9. YK-4-279
    A3946 YK-4-279
    Target: RHA
    Summary: RNA Helicase A (RHA) inhibitor
      insoluble in H2O; ≥16.35 mg/mL
  10. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL

Items 51-60 of 65

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 60item
  2. Natural Products 4item
  3. Protein 2item
  4. Peptides & Proteins 3item
  5. Lab Reagents 1 item
Specificity
  1. Selective 29item
Reversibility
  1. Irreversible 4item
Target
  1. Caspases 5item
  2. Cyclin-Dependent Kinases 1 item
  3. Proteasome 1 item
  4. Histone Deacetylases (HDACs) 3item
  5. Inhibitor of apoptosis proteins (IAP) 1 item
  6. Bcl-2 5item
  7. Raf 2item
  8. Aurora Kinases 1 item
  9. Bcl-xl 2item
  10. MDM2 1 item
  11. AP-1 1 item
  12. DT-diaphorases 1 item
  13. GSK-3 1 item
  14. VEGFR 2item
  15. PDGFR 2item
  16. c-Kit 2item
  17. RET 1 item
  18. Mcl-1 2item
  19. Thymidylate Synthase 1 item
  20. Nrf2 1 item
  21. Sir2-like Family Deacetylases (Sirtuins) 1 item
  22. Aminopeptidases 1 item
  23. STAT 1 item
  24. Estrogen and Related Receptors 1 item
  25. EGFR 1 item
  26. Hypoxia Inducible Factors (HIFs) 1 item
  27. JAK 3item
  28. HSP90 1 item
  29. Topoisomerases 1 item
  30. Cytochrome P450 (CYP450) 1 item
  31. MK2 1 item
  32. Autophagy 1 item
  33. NADPH Oxidases 1 item
  34. MAGL 1 item
  35. Histamine H1 Receptors 1 item
  36. TRP Channel 1 item
  37. Glucocorticoid Receptors 1 item
  38. Cdc7 1 item
  39. angiogenesis 1 item
  40. c-RET 1 item
  41. FPTase 1 item
  42. sodium channels 1 item
  43. p53 4item
  44. cysteine protease 1 item
  45. HDM2 ubiquitin ligase 1 item
  46. PC-PLC 1 item
  47. Glucosidases 1 item
  48. HIV 1 item
  49. Histone Acetyltransferases (HATs) 1 item
  50. Telomerases 1 item
  51. Tyrosinases 1 item
  52. HSP70 1 item
  53. phosphatidylinositol kinase 1 item
  54. Adenosine Deaminases 1 item
  55. p21 1 item
  56. DHFR 1 item
  57. GARFT 1 item
  58. RHA 1 item
  59. TRPC channel 1 item
  60. PKD 1 item
  61. Bcl-w 1 item
  62. Bax 1 item
  63. NS3/4a Proteases 1 item
Related Disease
  1. Breast Cancer 7item
  2. Cancer 29item
  3. Chronic Lymphocytic Leukemia 1 item
  4. Chronic Myeloproliferative Disorders 1 item
  5. Colon Cancer 2item
  6. Colon Carcinoma 1 item
  7. Colorectal Cancer 1 item
  8. Glioblastoma 2item
  9. HCV 1 item
  10. Inflammatory Diseases 1 item
  11. Leukemia 1 item
  12. Lymphoma 3item
  13. Melanoma 2item
  14. Multiple Myeloma 1 item
  15. Myelofibrosis 1 item
  16. Non-small Cell Lung Cancer 1 item
  17. Pain Relief 1 item
  18. Pancreatic Cancer 2item
  19. Pentacyclic Triterpenoid 1 item
  20. Prostate Cancer 5item
  21. Pulmonary Fibrosis 1 item
  22. Rheumatoid Arthritis 1 item
  23. Soft Tissue Sarcoma 1 item
  24. Type 2 Diabetes 1 item